Social Feeds
- $ CYRX Cryoport: The Bristol-Myers Acquisition of Celgene is a Validation of my Investment Thesis for Cryoport… https://t.co/TQ4KFbritg, Jan 09
- $PTLA Portola: Tidbits from Presentation at JP Morgan Healthcare Conference (PTLA, Buy, $21.96) https://t.co/76AuWyEbFH, Jan 09
- $BMY Negative Market Reaction to Celgene Acquisition is a Buying Opportunity https://t.co/0aybnueJbx, Jan 04
- $nwbo $46 million non-dilutive financing provides major boost to investment outlook. See my report. https://t.co/pidvWRoYUR, Dec 17
- $cyrx Cryoport raises a $25 million warchest for acquisiitons https://t.co/OyAt5ZlY87, Dec 17
Contact Us @SmithOnStocks
